USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Breakthrough Innovations in Point-of-Care Diagnostics
Rapid Molecular Platforms, AI-Powered Workflows, Home-Based Testing, and Connected Care Models to Drive Decentralized Diagnostics
25-Aug-2026
Global
Technology Research
DBA5-01-00-00-00
HC_2026_34842
This research analyzes how point-of-care (PoC) diagnostics is evolving from simple tests to decentralized, connected, and clinically actionable testing platforms across hospitals, outpatient settings, homes, and pharmacies.
The study assesses key technology shifts, including rapid molecular testing, lateral flow assays, microfluidics, biosensors, smartphone-based testing, AI-powered data interpretation, EHR integration, and cloud connectivity.
It also evaluates innovation momentum, emerging technologies, funding activity, case studies, patent landscape, and key growth opportunities, and it covers PoC diagnostics adoption across clinical settings, including hospitals, at-home, outpatient clinics, and pharmacies.
Key questions covered in this research study are:
Which PoC diagnostic technologies are enabling faster and decentralized clinical decision-making?
How are AI, connectivity, and digital workflows improving PoC test interpretation and clinical integration?
How are the patent and funding activities shaping the competitive positioning of the companies in the PoC diagnostics market?
Which therapeutic conditions, such as cardiovascular, respiratory infections, kidney disease, women’s health, and oncology, are creating new growth opportunities in the PoC diagnostics market?
Scope of Analysis
Overview of Point-of-Care Diagnostics
Evolution of the PoC Diagnostics
Segmentation
Why Is It Increasingly Difficult to Grow? The Strategic Imperative 8™: Factors Creating Pressure on Growth
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Point-of-Care Diagnostics Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Research Methodology
Growth Drivers
Growth Restraints
Key Innovations in Point-of-Care Diagnostics—Hospital-Based Testing
Key Innovations in Point-of-Care Diagnostics—Outpatient Clinics/Doctors' Offices
Key Innovations in Point-of-Care Diagnostics—Retail and Pharmacies
Key Innovations in Point-of-Care Diagnostics—Home-Based Testing
Key Innovations in Point-of-Care Diagnostics—Mobile Testing Setting/Public Health Campaigns
AI-Enabled Interpretation in PoC Diagnostics
Smartphone-Linked, Cloud-Connected, and EHR-Integrated PoC Workflows
Wearable and Continuous Diagnostics for Real-Time Monitoring
Technology Trends in PoC Diagnostics
Funding/Investment Analysis
Case Study 1—At-Home Cardiovascular Risk Screening Improved NHS Health Check Update
Case Study 2—Bedside Cardiopulmonary POCUS Reduces Hospital Stay and Costs for Patients with Undifferentiated Dyspnea
Case Study 3—PoC HPV Testing and Same-Day Colposcopy Improve Cervical Screening in Remote Settings
Future Outlook for PoC Diagnostics
Patents Published from 2023 to 2025
Key Patents
Growth Opportunity 1: Same-Visit Women's Health Testing
Growth Opportunity 2: Chronic Diseases Risk Screening at Point of Care
Growth Opportunity 3: Maternal and Neonatal Risk Triage in Decentralized Settings
Growth Opportunity 4: Non-Invasive Early Cancer Detection
Technology Readiness Levels (TRL): Explanation
Benefits and Impacts of Growth Opportunities
Next Steps
Legal Disclaimer
Speak directly with our analytics experts for tailored recommendations.
Recent related In Vitro Diagnostics (IVD) research
21 Aug 2026 | Global | Technology Research
Innovations and Growth Opportunities in AI-Driven Biomanufacturing, Advanced Cell and Gene Therapies, and Precision Immunotherapy
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping biomanufacturing, cell and gene therapy, precision immunotherapy, anti-infectives, and neurotherapeutics across oncology, infectious disease...
07 Aug 2026 | Global | Customer Research
Laboratory Product Purchasing Trends, United States and Europe, 2025–2026
Qualified respondents to this Frost & Sullivan survey were invited to participate in an online survey examining their laboratory’s product purchasing process in 2025 and expectations for 2026. Frost & Sullivan has conducted similar studies among the same target respondent groups since 2012. The su...
21 Jul 2026 | Global | Market Research
Point-of-Care Testing Market, Global, 2024–2031
The global POCT market is rapidly evolving from standalone rapid diagnostics to connected, AI-enabled clinical intelligence ecosystems that support decentralized healthcare delivery. Growth is driven by the increasing demand for faster clinical decision-making, early disease detection, personalized ...
17 Jul 2026 | Global | Technology Research
Innovations and Growth Opportunities in AI-Driven Drug Discovery, Precision Diagnostics, Advanced Biologics, and Next-generation Vaccines
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping drug discovery, diagnostics, and therapeutic delivery across oncology, infectious diseases, rare and autoimmune disorders, metabolic and age...
08 Jul 2026 | Global | Technology Research
Precision Obesity Management: AI-Guided Metabolic Modulation
The report explores the transformation of obesity care from generalized BMI-based treatment to AI-enabled precision metabolic management. The study highlights how obesity is increasingly recognized as a heterogeneous, multi-pathway disease influenced by genetic, neurobehavioral, metabolic, and envir...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
The study assesses key technology shifts, including rapid molecular testing, lateral flow assays, microfluidics, biosensors, smartphone-based testing, AI-powered data interpretation, EHR integration, and cloud connectivity.
It also evaluates innovation momentum, emerging technologies, funding activity, case studies, patent landscape, and key growth opportunities, and it covers PoC diagnostics adoption across clinical settings, including hospitals, at-home, outpatient clinics, and pharmacies.
Key questions covered in this research study are: Which PoC diagnostic technologies are enabling faster and decentralized clinical decision-making? How are AI, connectivity, and digital workflows improving PoC test interpretation and clinical integration? How are the patent and funding activities shaping the competitive positioning of the companies in the PoC diagnostics market? Which therapeutic conditions, such as cardiovascular, respiratory infections, kidney disease, women’s health, and oncology, are creating new growth opportunities in the PoC diagnostics market?
| Deliverable Type | Technology Research |
|---|---|
| Industries | Healthcare |
| No Index | No |
| Is Prebook | No |
| Podcast | No |
| Predecessor | None |
| WIP Number | DBA5-01-00-00-00 |